| NDC Code | 70461-121-03 |
|---|
| Package Description | 10 SYRINGE, GLASS in 1 CARTON (70461-121-03) > .5 mL in 1 SYRINGE, GLASS (70461-121-04) |
|---|
| Product NDC | 70461-121 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Fluad Quadrivalent |
|---|
| Non-Proprietary Name | Influenza Vaccine, Adjuvanted |
|---|
| Dosage Form | INJECTION, SUSPENSION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20200221 |
|---|
| End Marketing Date | 20220731 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125510 |
|---|
| Manufacturer | Seqirus, Inc. |
|---|
| Substance Name | INFLUENZA A VIRUS A/CAMBODIA/E0826360/2020 IVR-224 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 ANTIGEN (FORMALDEHYDE INACTIVATED) |
|---|
| Strength | 15; 15; 15; 15 |
|---|
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
|---|